Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
CC transcript
|
|
CATALYST BIOSCIENCES, INC. (CBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/22/2022 |
SC 13D/A
| JEC II Associates, LLC reports a 0% stake in Catalyst Biosciences, Inc. |
| 08/19/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 7.1% stake in Catalyst Biosciences, Inc. |
| 08/03/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 7.1% stake in Catalyst Biosciences, Inc. |
| 08/01/2022 |
SC 13D/A
| JEC II Associates, LLC reports a 8% stake in Catalyst Biosciences, Inc. |
| 07/22/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 7.1% stake in Catalyst Biosciences, Inc. |
| 07/01/2022 |
SC 13D/A
| JEC II Associates, LLC reports a 8% stake in Catalyst Biosciences, Inc. |
| 06/17/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 6.4% stake in Catalyst Biosciences, Inc. |
| 05/25/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 6.4% stake in Catalyst Biosciences, Inc. |
| 05/10/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in Catalyst Biosciences, Inc. |
| 05/02/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in [1] Catalyst Biosciences, Inc. |
| 04/21/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in [1] Catalyst Biosciences, Inc. |
| 03/16/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in Catalyst Biosciences, Inc. |
| 03/07/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in Catalyst Biosciences, Inc. |
| 02/28/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4.2% stake in Catalyst Biosciences, Inc. |
| 02/22/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 4% stake in Catalyst Biosciences, Inc. |
| 01/27/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 2.5% stake in Catalyst Biosciences, Inc. |
| 01/05/2022 |
SC 13D/A
| SINGER JULIAN D. reports a 2.5% stake in Catalyst Biosciences, Inc. |
| 08/05/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/17/2020 |
SC 13D/A
| SINGER JULIAN D. reports a 3.3% stake in Catalyst Biosciences, Inc. |
| 12/30/2019 |
SC 13D/A
| SINGER JULIAN D. reports a 3.3% stake in Catalyst Biosciences, Inc. |
| 02/14/2018 |
SC 13D/A
| Morgenthaler Partners VIII LP reports a 0% stake in Catalyst Biosciences, Inc. |
| 02/09/2018 |
SC 13D/A
| HealthCare Ventures VIII, L.P. reports a 1.7% stake in CATALYST BIOSCIENCES, INC. |
| 05/23/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/29/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/29/2008 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 10 L P reports a 18.9% stake in Targacept, Inc. |
|
|